Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
Paul M Elsbernd, Jonathan L Carter Department of Neurology, Mayo Clinic, Scottsdale, AZ, USACorrespondence: Jonathan L CarterDepartment of Neurology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USATel +1-480-301-8100Fax +1-480-301-8451Email carter.jonathan@mayo.eduAbstract: Monocl...
Guardado en:
Autores principales: | Elsbernd PM, Carter JL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c91e8bc3c8248e58ce948176146391f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
por: Cohan S
Publicado: (2016) -
Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Sylwia Pietrasik, et al.
Publicado: (2021) - Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Nutrition in Multiple Sclerosis: An integrative review of scientific publications from the last 5 years
por: Silva,Bruna Yhang da Costa, et al.
Publicado: (2019) -
Multiple sclerosis international
Publicado: (2010)